Rhenman & Partners Asset Management AB / PFE
Rhenman & Partners Asset Management AB’s Pfizer Inc Position
Does Rhenman & Partners Asset Management AB own Pfizer Inc (PFE)? Not currently — the last reported position was 580.0K shares worth $17M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$17M
Q4 2023
Shares
580.0K
% of Portfolio
+1.67%
Quarters Held
12
position exited
Position History PFE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2023 | 580.0K | $17M | +1.67% |
| Q1 2023 | 190.0K | $8M | +0.84% |
| Q4 2022 | 350.0K | $18M | +1.87% |
| Q3 2022 | 350.0K | $16M | +1.71% |
| Q2 2022 | 540.0K | $28M | +3.22% |
| Q1 2022 | 522.5K | $27M | +2.67% |
| Q4 2021 | 1.00M | $58M | +3.88% |
| Q3 2021 | 1.00M | $43M | +3.02% |
| Q2 2021 | 500.0K | $20M | +1.33% |
| Q2 2020 | 4.5K | $147,000 | +0.02% |
| Q1 2019 | 5.0K | $213,000 | +0.02% |
| Q4 2018 | 5.0K | $219,000 | +0.03% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rhenman & Partners Asset Management AB’s full portfolio or all institutional holders of PFE.